Editas Medicine, Inc. (EDIT)
1.77
-0.06
(-3.01%)
USD |
NASDAQ |
Nov 18, 16:00
1.80
+0.03
(+1.69%)
After-Hours: 20:00
Editas Medicine 30-Day Average Daily Volume : 2.386M for Nov. 17, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 17, 2026 | 2.386M |
| November 16, 2026 | 2.415M |
| November 13, 2026 | 2.445M |
| November 12, 2026 | 2.424M |
| November 11, 2026 | 2.346M |
| November 10, 2026 | 2.334M |
| November 09, 2026 | 2.333M |
| November 06, 2026 | 2.283M |
| November 05, 2026 | 2.329M |
| November 04, 2026 | 2.346M |
| November 03, 2026 | 2.439M |
| November 02, 2026 | 2.457M |
| October 30, 2026 | 2.499M |
| October 29, 2026 | 2.970M |
| October 28, 2026 | 2.979M |
| October 27, 2026 | 2.915M |
| October 26, 2026 | 2.868M |
| October 23, 2026 | 2.879M |
| October 22, 2026 | 2.918M |
| October 21, 2026 | 2.967M |
| October 20, 2026 | 3.028M |
| October 19, 2026 | 3.028M |
| October 16, 2026 | 3.008M |
| October 15, 2026 | 3.002M |
| October 14, 2026 | 2.996M |
| Date | Value |
|---|---|
| October 13, 2026 | 2.942M |
| October 12, 2026 | 2.930M |
| October 09, 2026 | 2.996M |
| October 08, 2026 | 2.982M |
| October 07, 2026 | 2.878M |
| October 06, 2026 | 2.942M |
| October 05, 2026 | 2.912M |
| October 02, 2026 | 2.882M |
| October 01, 2026 | 2.952M |
| September 30, 2026 | 3.222M |
| September 29, 2026 | 3.242M |
| September 28, 2026 | 3.260M |
| September 25, 2026 | 3.236M |
| September 24, 2026 | 3.175M |
| September 23, 2026 | 3.143M |
| September 22, 2026 | 3.034M |
| September 21, 2026 | 3.006M |
| September 18, 2026 | 2.980M |
| September 17, 2026 | 2.526M |
| September 16, 2026 | 2.474M |
| September 15, 2026 | 2.443M |
| September 14, 2026 | 2.412M |
| September 11, 2026 | 2.395M |
| September 10, 2026 | 2.341M |
| September 09, 2026 | 2.307M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.651M |
| Vertex Pharmaceuticals, Inc. | 1.513M |
| Recursion Pharmaceuticals, Inc. | 25.05M |
| Halozyme Therapeutics, Inc. | 2.322M |
| Novavax, Inc. | 6.973M |